Out-of-hours admissions in patients treated with immune checkpoint inhibitors and their primary management with steroids

Shorter versus longer corticosteroid duration and recurrent immune checkpoint inhibitor-associated AKI

(2022) Shruti Gupta et al.   Journal for ImmunoTherapy of Cancer

The combined use of steroids and immune checkpoint inhibitors in brain metastasis patients: a systematic review and meta-analysis

(2021) Charissa A C Jessurun et al.   NEURO-ONCOLOGY

The Inconsistent and Inadequate Reporting Of Immune‐Related Adverse Events in PD ‐1/ PD‐L1 Inhibitors: A Systematic Review of Randomized Controlled Clinical Trials

(2021) Tong Xie et al.   ONCOLOGIST

Emergency presentations in patients treated with immune checkpoint inhibitors

(2020) Tim Cooksley et al.   EUROPEAN JOURNAL OF CANCER

Retrospective analysis of hospital admissions due to immune checkpoint inhibitor‐induced immune‐related adverse events (irAE)

(2020) Elizabeth Ahern et al.   Asia-Pacific Journal of Clinical Oncology

Immunotherapy and associated immune-related adverse events at a large UK centre: a mixed methods study

(2020) Liz Jamieson et al.   BMC CANCER

Impact of out-of-hours admission on patient mortality: longitudinal analysis in a tertiary acute hospital

(2017) Lu Han et al.   BMJ Quality & Safety

Management of toxicities of immune checkpoint inhibitors

(2016) Lavinia Spain et al.   CANCER TREATMENT REVIEWS

Weekend hospitalization and additional risk of death: An analysis of inpatient data

(2012) N Freemantle et al.   JOURNAL OF THE ROYAL SOCIETY OF MEDICINE